Home / News / India News / Article / Serum Institute asks govt to speak with EU for inclusion

Serum Institute asks govt to speak with EU for inclusion

Co says exclusion will affect students, business travellers, economy; Europe allows Oxford-AstraZeneca vaccine, but not Covishield which is its locally manufactured version

Listen to this article :
Beneficaries wait in a queue to receive Covid-19 vaccine dose, at a district hospital in Noida, on Monday. Pic/PTI

Beneficaries wait in a queue to receive Covid-19 vaccine dose, at a district hospital in Noida, on Monday. Pic/PTI

Serum Institute of India (SII) has requested the Centre to take up the matter of inclusion of Covishield vaccine in the EU Covid-19 Vaccination Passport with the European Union and other countries, citing this will affect students and business travellers and cause severe disruptions to the Indian and global economy.

Only four vaccines — Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson’s Janssen — have been approved by the European Medicines Agency (EMA) and only those vaccinated by these vaccines will be given vaccination passports and will be allowed to travel within the EU during the pandemic.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
Drones sighted over military station in Jammu again

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement